OREGON STATE UNIVERSITY
Open search box
| Title | Sponsor | Award |
|---|---|---|
|
Peer Review of PCORI's Funded Research |
Oregon Health and Science University |
$45,757 |
|
Intervention to Increase Naloxone Engagement and Distribution in Community Pharmacies: A Four-State Randomized Trial |
Boston University |
$16,446 |
|
Biosynthetic studies and development of ribomimetic-based anti-infectives |
National Institutes of Health |
$357,955 |
|
EpiCenter - EPIdemiology of opioid prescribing in community health CENTERs |
Oregon Health and Science University |
$36,824 |
|
Oregon Clinical and Translational Research Institute KL2 Program |
Oregon Health and Science University |
$35,165 |
|
The Chemical Ecology and Group Dynamics of Modern Microbialite Communities |
Gordon and Betty Moore Foundation |
$299,487 |
|
Implementation, Outcomes, and Cost of a Novel Medicaid Policy to Reduce Opioids for Back Pain |
Oregon Health and Science University |
$89,636 |
|
Nanoparticles based mRNA delivery for treatment of cystic fibrosis |
National Institutes of Health |
$658,627 |
|
Discovery and Biological Signatures of Microbiome-Derived Xanthohumol Metabolites and their Role in Ameliorating Inflammatory Bowel Disease |
National Institutes of Health |
$960,276 |
|
Reducing Overdose After Release from Incarceration (ROAR) |
Oregon Health and Science University |
$92,497 |
|
Improving access to care through pharmacist prescription of hormonal contraception |
Oregon Health and Science University |
$14000 |
|
Optimizing Antibiotic Prescribing on Discharge to Long-term Care Facilities |
Agency for Healthcare Research and Quality |
$547,351 |
|
Modulation of Protein Biogenesis and Secretion by Natural Product Translocon Ligands |
National Institutes of Health |
$388,638 |
|
Novel Nanomedicine-Based Therapeutic Approach For Treatment of Cancer Cachexia |
National Institutes of Health |
$446,372 |
|
Validation of preclinical assays with clinical data to evaluate the safety of estrogenic botanical dietary supplements |
National Institutes of Health |
$41,443 |
|
Research Training in Natural Product Complementary and Integrative Health |
National Institutes of Health |
$248,169 |
|
Intravascular Delivery of Nanoclusters for Treatment of Deep-Seated Cancers with Magnetic Hyperthermia |
National Institutes of Health |
$614,464 |
|
A nanoparticle-based approach for surgical imaging and intraoperative treatment of endometriosis |
Oregon Health and Science University |
$103,023 |
|
Near Infrared Nerve-specific Fluorophores for Clinical Fluorescence Guided Surgery |
Oregon Health and Science University |
$12,632 |
|
Novel Materials for Gene Delivery to treat CF |
Cystic Fibrosis Foundation |
$267,433 |
|
Overcoming gene delivery barriers to the back of the eye |
National Institutes of Health |
$238,145 |
|
Developing a novel antibiogram tool to improve empiric antibiotic prescribing in nursing homes |
University of Wisconsin |
$44,735 |
|
Oregon HIV/Hepatitis and Opioid Prevention and Engagement (OR-HOPE) study |
Oregon Health and Science University |
$30,420 |
|
Intervention to Increase Naloxone Engagement and Distribution in Community Pharmacies: A Four-State Randomized Trial |
Brandeis University |
$133,930 |
|
Metabolic response to traditional diets in Alaska Native people |
Oregon Health and Science University |
$74,375 |
|
Prescription Drug Monitoring Program Integration in the Electronic Health Record |
Agency for Healthcare Research and Quality |
$140,846 |
|
ApoE Isoform-Dependent Changes in Brain Bioenergetics Post-Menopause in Response to Xanthohumol |
Collins Medical Trust |
$30,000 |
|
IIR 17-039 Improving Veteran Health by Increasing Dental Stewardship of Antibiotics and Opioids |
Oregon Dept. of Veterans' Affairs |
$19,373 |
|
Collaborative Research: CompCog:Psychological, computational, and neural adequacy in a deep learning model of human speech recognition |
National Science Foundation |
$178,934 |
|
Small Molecule screen for inhibition of SARS-CoV-2 |
ReSeptr Therapeutics, LLC |
$21,650 |
|
Dual anti-CD47 and Duramycin Functionalized Carriers for Radio-enhanced Drug Delivery |
PhRMA Foundation |
$25,000 |
|
Flip the Pharmacy (FtP) PracNce TransformaNon Team (PTT) |
GPP Solutions, LLC |
$6,250 |
|
Lipid Nanoparticle Delivery of Saliogase EDIT Technology |
SalioGen Therapeutics |
$99,178 |
|
Nanoparticle mediated delivery of modified CFTR mRNA for treatment of cystic fibrosis |
Cystic Fibrosis Foundation |
$63,350 |
|
Microbiota, Tertiary Lymphoid Structures and Chronic Inflammation in the Human Gut |
University of Massachusetts |
$111,375 |
|
Understanding the impact of radiation on endocytosis of small molecule therapies and their nanoformulations |
American Foundation for Pharmaceutical Education |
$5,000 |
|
Role of Non-calcemic vitamin D-hydroxyderivatives as preventive agents in melanoma |
Oregon Health and Science University |
$50,000 |
|
New technologies for inhalable nanoparticles |
Rare Air Health, LLC |
$31,733 |
|
Prepare CPD100Li formulation |
Cascade ProDrug Inc | $92,152 |
|
Lipid nanoparticles for gene editing |
Beam Therapeutics |
$390,932 |
| Agency | Type | Grant Code | Award |
|---|---|---|---|
|
Health and Environmental Sciences Institute (HESI) |
Cooperative Agreement | J25520 | $9,200 |
|
Circ Bio Inc. (CBIN) |
Contract | VC3070 | $370,400 |
|
CTI Biopharma (CTIB) |
Contract | VC3000 | $39,377 |
|
EnterX Biosciences, Inc. (EXBI) |
Contract | VC2960 | $266,493 |
|
Liphatech (LXXX) |
Contract | VC3160 | $158,000 |
|
Rare Air Health, LLC (RAHL) |
Contract | VC2680 | $123,834 |
|
ReSeptr Therapeutics, LLC (RSTL) |
Contract | VC2480 | $43,300 |
| American Foundation for Pharmaceutical (AFPE) | Grant | F11480 | $5,000 |
| Cystic Fibrosis Foundation (CFFX) | Grant | F10610 | $481 |
| National Institutes of Health (NIH) | Grant |
P05380 |
$5,368,653 |
| Dartmouth-Hitchcock Clinic (DHCX) | Sub Grant | U14880 | $13,719 |
| Henry M Jackson Foundation (HMJF) | Sub Grant | F10630 | $512,336 |
| Inherent Targeting LLC (INTA) | Sub Grant | V09070 | $22,433 |
| Massachusetts General Hospital (MGHX) | Sub Grant | J25670 | $185,625 |
| Oregon Health & Science University (OHSU) | Sub Grant | U15700 | $126,736 |
| University of Massachusetts Medical School (UMMS) | Sub Grant | U15480 | $92,813 |
| Agency for Healthcare Research and Quality (AHRQ) | Grant |
P04770 P05310 |
$226,825 |
| US Department of Veterans Affairs (DVAX) | Interagency Personnel Agreement | X02290 | $39,823 |
| Brandeis University (BRAN) | Sub Grant | U14370 | $106,582 |
| Oregon Health & Science University (OHSU) | Sub Grant |
U13070 U13180 U13260 U14360 U15580 |
$286,439 |
| University of Wisconsin - Madison (UWMX) | Sub Grant | U15840 | $44,735 |
| Total: | $8,042,804 |
| Agency | Type | Grant Code | Award |
|---|---|---|---|
| PHR - Basic Pharm Sci Operations | Primary PI | |||
|
Liphatech (LXXX) |
Contract | VC3160 | $315,000 |
| Army (ARMY) | Grant | RM1560 | $519,747 |
| Cystic Fibrosis Foundation (CFFX) | Grant | F11000 | $1,467,315 |
| California Table Grape Commission (CTGC) | Grant | Y06860 | $89,000 |
| Gordon and Betty Moore Foundation (GBMF) | Grant | F10000 | $3 |
| M.J. Murdock Charitable Trust | Grant | F12180 | $700,000 |
| National Institutes of Health (NIH) | Grant |
P04760 |
$6,018,203 |
| National Science Foundation (NSFX) | Grant | S23920 | $186,479 |
| Henry M Jackson Foundation (HMJF) | Sub Grant | F10630 |
$259,154 |
| Oregon Health & Science University | Sub Grant |
U15700 U16970 |
$160,081 |
| Pacific University (PUXX) | Sub Grant | U13710 | $38,610 |
| University of Illinois, Chicago (UICX) | Sub Grant | U16780 | $114,215 |
| University of Massachusetts Medical School (UMMS) | Sub Grant | U16330 | $62,517 |
| Washington State University | Sub Grant | UX3220 | $100,425 |
| Subtotal: | $10,030,750 | ||
| Agency | Type | Grant Code | Award |
|---|---|---|---|
| PHR - Pharmacy Practice Operations | Primary PI | |||
|
US Department of Veterans Affairs (DVAX) |
Contract | X02610 | $25,787 |
| National Institutes of Health (NIH) | Grant | P05520 | $483,221 |
| Brandeis University (BRAN) | Sub Grant | U14370 | $70,087 |
| Oregon Health & Science University (OHSU) | Sub Grant |
U13070 U13180 U14360 U15580 U16770 |
$275,127 |
| University of Colorado Denver (UCOD) | Sub Grant | U17110 | $15,816 |
| University of Wisconsin - Madison (UWMX) | Sub Grant | U16990 | $61,080 |
| Abt Associates (ABTA) | Sub Contract | V09430 | $445,448 |
| Subtotal: | $1,376,567 | ||
| Agency | Type | Grant Code | Award |
|---|---|---|---|
| PHR - Basic Pharm Sci & Pharmacy Practice Operations | PI Type Not Found - Grant Proposal not found | |||
|
Henry M Jackson Foundation (HMJF) |
Sub Grant | F10620 | $57,452 |
| University of Wisconsin - Madison (UWMX) | Sub Grant | U15840 | $599 |
| Subtotal: | $58,051 | ||
| PHR - Basic Pharm Sci Operations | Primary PI | Subtotal: | $10,030,750 |
| PHR - Pharmacy Practice Operations | Primary PI | Subtotal: | $1,376,567 |
|
PHR - Basic Pharm Sci & Pharmacy Practice Operations PI Type Not Found - Grant Proposal not found |
Subtotal: | $58,051 |
| Subtotal: | $11,465,368 | |